OMCL vs NXST Stock Comparison: AI Score, Valuation, Performance and Upside
OMCL (Omnicell) and NXST (Nexstar) are very different businesses — Omnicell providing hospital pharmacy automation with a software transition underway, and Nexstar operating the largest U.S. local television broadcasting group navigating cord-cutting headwinds. These companies rarely appear in direct comparison except in diversified mid-cap screens.
OMCL vs NXST contrasts a healthcare technology automation company undergoing a software business model transition against a traditional local broadcasting company navigating secular cord-cutting pressures.
NXST holds the edge across 3 of 5 key metrics in this comparison. OMCL has delivered stronger 1-year price return (+1.35% vs -24.16%), though NXST has the better forward P/E setup (7.60x vs 16.61x for OMCL). NXST leads on both revenue growth (62.20%) and operating margin (21.22%), suggesting a stronger fundamental setup on both dimensions. Analyst consensus implies meaningfully more upside for OMCL (+66.69%) than for NXST (+39.26%).
Human Wall Street analysts' price targets, typically implying a ~12-month view — a separate signal from this site's own AI Prediction Signal further down the page, which is a 5-/30-day machine-learning forecast based on price history alone.
- Want hospital pharmacy automation exposure with a recurring software and services transformation underway
- Value Omnicell's dominant dispensing cabinet installed base as a platform for Advanced Services outsourcing revenue
- See healthcare automation as a growing priority as hospitals seek to reduce medication errors and pharmacy costs
- Want local TV broadcasting exposure at a discounted valuation reflecting cord-cutting headwinds
- Value political advertising revenue cyclicality as a predictable above-average earnings boost in election years
- See Nexstar's scale and retransmission contract negotiation leverage as providing revenue stability despite secular challenges
| Metric | OMCL | NXST |
|---|---|---|
| AI scorei | 25.7 | 49.6 |
| AI ranki | #2719 | #565 |
| Latest closei | $32.23 | $156.53 |
| 1M returni | -11.53% | -16.46% |
| 6M returni | -2.60% | -29.82% |
| 1Y returni | +1.35% | -24.16% |
How much would $10,000 be worth today if invested at the start of each period, with all dividends reinvested?
| Period | OMCL | NXST |
|---|---|---|
| 1Y ago | $10.14K (+1.4%) started 2025-09-18 | $7.58K (-24.2%) started 2025-09-18 |
| 5Y ago | $2.09K (-79.1%) started 2021-09-20 | $10.74K (+7.4%) started 2021-09-20 |
| 10Y ago | $8.55K (-14.5%) started 2016-09-19 | $28.78K (+187.8%) started 2016-09-19 |
Hypothetical — past performance does not guarantee future results.
| Metric | OMCL | NXST |
|---|---|---|
| Market capi | $1.58B | $5.46B |
| Trailing P/Ei | 41.32 | 33.56 |
| Forward P/Ei | 16.61 | 7.60 |
| Price/Salesi | N/A | N/A |
| EV/Revenuei | 1.19 | 2.95 |
| Analyst targeti | $57.86 | $246.75 |
| Target upsidei | +66.69% | +39.26% |
| Metric | OMCL | NXST |
|---|---|---|
| Revenue growthi | 7.50% | 62.20% |
| Earnings growthi | 333.30% | 18.00% |
| EPS growthi | +333.30% | +18.00% |
| FCF margini | +10.76% | +13.63% |
| Operating margini | 5.91% | 21.22% |
| Profit margini | 3.14% | 3.20% |
| ROIC proxyi | 3.06% | 7.43% |
| Return on equityi | 3.06% | 7.43% |
| Dividend yieldi | N/A | 4.18% |
| Payout ratioi | 0.00% | 140.91% |
| Dividend growth streaki | N/A | N/A |
| Betai | 0.97 | 0.90 |
| Debt/equityi | 15.48 | 533.79 |
| Current ratioi | 1.64 | 1.56 |
| Quick ratioi | 1.19 | 1.40 |
Over the past year, OMCL and NXST have moved weakly in the same direction (correlation of 0.20), based on daily returns.
Lower drawdown and smaller single-period drops generally indicate a smoother ride, though they do not guarantee lower future risk.
| Period | Metric | OMCL | NXST |
|---|---|---|---|
| 1Y | Growthi | +1.35% | -24.16% |
| CAGRi | +1.35% | -24.18% | |
| Volatilityi | 50.39% | 35.54% | |
| Sharpe ratioi | 0.19 | -0.73 | |
| Sortino ratioi | 0.28 | -0.98 | |
| Max drawdowni | 37.28% | 39.01% | |
| Current drawdowni | 37.28% | 38.29% | |
| Avg drawdowni | 16.13% | 15.78% | |
| Ulcer Indexi | 20.29% | 19.63% | |
| Max daily dropi | 16.30% | 13.11% | |
| Max wkly dropi | 25.05% | 19.57% | |
| 5Y | Growthi | -79.10% | +7.37% |
| CAGRi | -26.91% | +1.43% | |
| Volatilityi | 51.15% | 34.95% | |
| Sharpe ratioi | -0.45 | 0.09 | |
| Sortino ratioi | -0.64 | 0.12 | |
| Max drawdowni | 86.59% | 39.01% | |
| Current drawdowni | 82.45% | 38.29% | |
| Avg drawdowni | 66.09% | 16.73% | |
| Ulcer Indexi | 70.08% | 19.32% | |
| Max daily dropi | 34.52% | 13.11% | |
| Max wkly dropi | 36.66% | 19.57% | |
| 10Y | Growthi | -14.46% | +187.84% |
| CAGRi | -1.55% | +11.16% | |
| Volatilityi | 44.34% | 39.83% | |
| Sharpe ratioi | 0.09 | 0.35 | |
| Sortino ratioi | 0.12 | 0.51 | |
| Max drawdowni | 86.59% | 64.72% | |
| Current drawdowni | 82.45% | 38.29% | |
| Avg drawdowni | 37.92% | 15.06% | |
| Ulcer Indexi | 50.40% | 18.62% | |
| Max daily dropi | 34.52% | 19.09% | |
| Max wkly dropi | 36.66% | 34.83% |
| Category | OMCL | NXST |
|---|---|---|
| Company | Omnicell, Inc. | Nexstar Media Group, Inc. |
| Sector | Healthcare | Communication Services |
| Industry | Health Information Services | Broadcasting |
| Core business | Omnicell provides pharmacy automation and medication management solutions to hospitals and health systems, including automated dispensing cabinets, central pharmacy automation, IV compounding robots, and a cloud-based pharmacy intelligence platform. | Nexstar is the largest local television broadcasting company in the United States by station count, operating and providing services to over 200 full power television stations and various digital media assets in markets across the country. |
| Investor focus | Investors track Omnicell's recurring connected devices and software revenue, Advanced Services (pharmacy-as-a-service) adoption, and the company's transition from hardware-focused to software and services-led revenue. | Investors track Nexstar's retransmission consent revenue from cable and satellite providers, political advertising revenue in election years, and the company's ability to manage declining core advertising with growing digital and retransmission revenues. |
- Dominant position in hospital automated dispensing cabinets creates sticky recurring revenue from service and software contracts
- Advanced Services pharmacy outsourcing model provides health systems with predictable pharmacy operations costs
- Medication management automation addresses critical hospital priorities around medication error reduction and pharmacy efficiency
- Largest U.S. local TV broadcaster by station count provides significant scale for retransmission consent negotiation leverage
- Political advertising creates significant revenue bump in election years, providing above-average earnings in even-numbered years
- CW Network acquisition provides national broadcast network content and distribution reach
- Hospital capital budget pressures can delay automation purchases, making hardware revenues lumpy
- Transition from hardware-centric to software/services model takes time and creates near-term revenue headwinds
- Competition from BD (Becton Dickinson) Pyxis systems in the core automated dispensing cabinet market
- Cord-cutting reduces cable and satellite subscribers who pay retransmission fees, the primary revenue growth driver
- Local TV advertising is in secular decline as digital advertising captures marketing budgets
- High debt from acquisition-driven growth constrains financial flexibility and amplifies cyclical earnings volatility
Want deeper AI forecasts?
This comparison page is public and free forever. Subscribers can unlock saved watchlists, full AI rankings, detailed forecasts, and interactive analysis tools.